Drug profile · INN
ocriplasmin
JETREA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ocriplasmin (JETREA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravitreal. Current US regulatory status: approved.
Key facts
INN ocriplasmin
Brand JETREA
Route INTRAVITREAL
Formulation INJECTABLE
ATC code S01XA22
Frequently asked questions
What is ocriplasmin?
ocriplasmin (JETREA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravitreal. Current US regulatory status: approved.
What is the brand name for ocriplasmin?
JETREA is a marketed brand name for ocriplasmin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ocriplasmin?
ocriplasmin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.